GSK Holds Out Vaccine Hopes
GlaxoSmithKline shares jumped 2% after the pharmaceutical giant reported strong full-year results. Full-year profit rose 5% at consistent exchange rates to £30. 3 billion, up 14% on the year.
GlaxoSmithKline shares jumped 2% after the pharmaceutical giant reported strong full-year results. Full-year profit rose 5% at consistent exchange rates to £30. 3 billion, up 14% on the year.
PRESS RELEASEBrussels, 2 February 2024 (17.45)World leader in aluminium anodising 2023 SALES OF €21.8M IMPACTED BY A CHALLENGING ECONOMIC ENVIRONMENT COIL, world leader in aluminium anodising, announces
Coil: a turnover of €21. 8 million in 2023 impacted by a difficult economic environment Read More »
As a student, Inge Neven (47) from Zelem advanced the power of mixed combines. Later, he launched projects in West Africa and tackled the coronavirus crisis in Brussels. Today, Neven is the executive director of VITO, where the most sensible researchers work for a more sustainable world.
Inge Neven, from Limburg, leads 1,200 scientists who will travel the world Read More »
LIBERTY LAKE, Wash. , Jan. 31, 2024 – Itron is partnering with Lightwell to supply Fluvius with Itron’s smart street lighting solution for CO2 emissions and energy waste.
The EU will step up its efforts on physical care and vaccine production in Africa to ensure the continent can respond to long-term health emergencies, EU Health Commissioner Stella Kyriakides said on Monday.
EU commits to post-Covid Africa’s “health sovereignty” Read More »
China’s COVID isolation protocols have put Belgian Olympian Kim Meylemans through an emotional test in Beijing.
Belgian Olympian Kim Meylemans cries over COVID isolation in Beijing Read More »
Novo Holdings, the asset manager of the foundation that controls Novo Nordisk, has agreed to acquire Catalent for $16. 5 billion. The customer will recoup two-thirds of that spend by promoting 3 of Catalent’s fill and finish sites to Novo Nordisk for $11 billion. The front.
Novo Holdings buys Catalent for $16. 5 billion; Sells 3 to Novo Nordisk for $11 billion Read More »
According to the latest EY CEO Outlook Pulse survey, global CEOs are optimistic about their ability to drive revenue growth and profitability in …
This is one of the first deals made through Dame Kate Bingham, who later rose to prominence as chair of the government’s task force on Covid vaccines. . . Evenity evolved and came to market through. . .